Add-Aspirin
A phase III double-blind, placebo-controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non-metastatic solid tumours
DADSPORT
Duration of androgen suppression with post-operative radiotherapy (DADSPORT): A meta-analysis of aggregate data
FOCUS4
A molecularly-stratified randomised controlled trial programme for patients with advanced colorectal (bowel) cancer
INCH
Induction chemotherapy and CHART in non-small cell lung cancer
Lung cancer: TKI inhibitors, systematic review and aggregate data meta-analysis
Should tyrosine kinase inhibitors be considered for advanced non-small cell lung cancer with wild type EGFR? Two systematic reviews and meta-analyses of randomised trials
PATCH (PR09)
A randomised controlled trial of transcutaneous oestrogen patches versus LHRH agonists in prostate cancer
RAMPART
An international investigator-led phase III multi arm multi stage multi-centre randomised controlled platform trial of adjuvant therapy in patients with resected primary renal cell carcinoma (RCC) at high or intermediate risk of relapse
REFINE
REduced Frequency ImmuNE checkpoint inhibition in cancers
STAMPEDE
Systemic Therapy in Advancing or Metastatic Prostate cancer: Evaluation of Drug Efficacy
STOPCAP M1 Programme
Prostate cancer: STOPCAP M1 Programme. Speeding up the evaluation of therapies for metastatic, hormone-sensitive prostate cancer
UKCTOCS
UK Collaborative Trial of Ovarian Cancer Screening
UKLWC
UKCTOCS Longitudinal Women’s Cohort
